X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Science Translational Medicine

期刊標題檢索 SCI TRANSL MED 最新評論: Will there be a response from the rejection? (2024-04-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Science Translational Medicine]您好,您是該頁面的第 170377 位訪客。

期刊簡介
期刊名稱Science Translational Medicine Science Translational Medicine
LetPub Score
9.3
50 ratings
Rate

Reputation
10.0

Influence
9.2

Speed
7.0

期刊簡稱SCI TRANSL MED
ISSN1946-6234
E-ISSN1946-6242
h-index168
CiteScore
CiteScoreSJRSNIPCiteScore Rank
26.706.5102.590
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: General Medicine
Q111 / 636

自引率 (2023-2024)0.60%自引率趨勢
掲載範囲
Science Translational Medicine Mission: To promote human health by providing a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners and trainees from all relevant established and emerging disciplines.

Scope: Cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.
官方網站http://stm.sciencemag.org/
在線稿件提交https://cts.sciencemag.org/scc/login.html
開放訪問No
出版商American Association for the Advancement of Science
主題領域CELL BIOLOGY
出版國/地區UNITED STATES
發行頻率週刊
創刊年2009
每年文章數271每年文章數趨勢
黃金OA百分比7.22%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ111/205
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ12/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1946-6234%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: Very difficult
參考鏈接
相關期刊 【Science Translational Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Stem Cell Research & TherapyH-index: 56

    CiteScore: 13.20
    Wiley Interdisciplinary Reviews-Nanomedicine and NanobiotechnologyH-index: 0

    CiteScore: 17.60
    EXPERT REVIEWS IN MOLECULAR MEDICINEH-index: 73

    CiteScore: 7.40
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINEH-index: 108

    CiteScore: 11.50
    Frontiers of MedicineH-index: 28

    CiteScore: 18.30
    Journal of Diabetes ResearchH-index: 33

    CiteScore: 8.40
    Biomed Research InternationalH-index: 94

    CiteScore: 6.70
    JOURNAL OF INVESTIGATIVE MEDICINEH-index: 59

    CiteScore: 11.20
    Journal of Cardiovascular Translational ResearchH-index: 44

    CiteScore: 6.10
    American Journal of Translational ResearchH-index: 45

    CiteScore: 5.30
    學科內最受檢索的期刊 頁面查看次數
    Biomed Research International394243
    American Journal of Translational Research162317
    Stem Cell Research & Therapy136111
    Frontiers of Medicine89018
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE78846
    Journal of Diabetes Research56355
    Journal of Cardiovascular Translational Research32071
    Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology30710
    EXPERT REVIEWS IN MOLECULAR MEDICINE17152
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION15937
  •  

    Science Translational Medicine Science Translational Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [Science Translational Medicine] 的評論撰寫評論
作者: 一只红香呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-17 22:07:42 評論於
Will there be a response from the rejection?
(0) 讚! | 一只红香呀

作者: 仙灵钰岩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-25 12:47:33 評論於
Please translate the following passage into English and Japanese, with the titles ":" and ":"
(0) 讚! | 仙灵钰岩

作者: 无极红香


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-03 11:31:43 評論於
sadasdasdasdad
(0) 讚! | 无极红香

作者: 京城代晴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-28 12:11:43 評論於
Do all authors need to agree during the initial submission stage?
(0) 讚! | 京城代晴

作者: 小野寺英悟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-24 23:44:16 評論於
Does it always stay under evaluation until the author agrees?
(0) 讚! | 小野寺英悟

作者: 龙鳞尚萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-02 18:02:00 評論於
How have you been progressing lately? Will a longer timeframe mean it can be sent for external review?
(0) 讚! | 龙鳞尚萍

作者: 龙鳞尚萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-02 16:30:39 評論於
How are you doing? Have you been reviewed? I have also been under evaluation for a week with no news
(0) 讚! | 龙鳞尚萍

作者: 猫巷少女田田


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-16 11:22:55 評論於
When will you reply to us? We have been under evaluation for a month now, and the status has not changed
(0) 讚! | 猫巷少女田田

作者: 半月文墨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-06 23:15:56 評論於
Do we need agreement from all authors?
(0) 讚! | 半月文墨

作者: 半月文墨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-03 15:04:36 評論於
It has been nearly a month since it is under evaluation, has the editor forgotten about it?
(0) 讚! | 半月文墨

作者: 无妄云超


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-14 23:20:23 評論於
I think as long as it has not been finally accepted, there is a possibility of rejection
(0) 讚! | 无妄云超

作者: 无妄云超


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-14 22:59:18 評論於
Some journals have low impact factors but high recognition, making it hard to submit articles. The difficulty of submission is not only determined by the impact factor
(0) 讚! | 无妄云超

作者: 蒙德艺硕


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-27 12:50:23 評論於
Can I ask, I keep getting an error message saying my password or account is incorrect when I try to log in, and it also says "your AAAS membership credentials will not work on this site." Is this normal?
(0) 讚! | 蒙德艺硕

作者: 桃花浩丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-17 11:39:04 評論於
Yes
(0) 讚! | 桃花浩丽

作者: 努力啊大保胜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-13 20:42:58 評論於
Do all authors have to agree to certification after submitting to this journal?
(0) 讚! | 努力啊大保胜

作者: 白云小宸


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-04 22:51:50 評論於
How long have you been in under evaluation?
(0) 讚! | 白云小宸

作者: 白云小宸


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-04 13:28:18 評論於
How long did the card get stuck for?
(0) 讚! | 白云小宸

作者: 白云小宸


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-29 08:49:58 評論於
How long did you get stuck for later?
(0) 讚! | 白云小宸

作者: Curitis Charles


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-29 15:42:46 評論於
Do you need to provide original data?
(0) 讚! | Curitis Charles

作者: 黑山思佳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-22 12:42:36 評論於
I would like to ask, will the paper be rejected after a review?
(0) 讚! | 黑山思佳

作者: 魔都小柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-19 17:34:40 評論於
Yes
(0) 讚! | 魔都小柔

作者: 黑山思佳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-16 21:32:34 評論於
I also want to know
(0) 讚! | 黑山思佳

作者: 光明继海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-21 22:37:35 評論於
What is the status of your situation now? Mine has been in "from revision" for over two months, and I haven't received any updates
(0) 讚! | 光明继海

作者: 光明继海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-21 14:40:39 評論於
All of my authors have confirmed, but it has been stuck in a certain state for more than two months
(0) 讚! | 光明继海

作者: 中原琦巧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-20 20:59:51 評論於
Can you share the timeline for when you revised it to be accepted?
(0) 讚! | 中原琦巧

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [Science Translational Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*